CEL-SCI Corporation CEL-SCI Corporation

CEL-SCI Corporation

CVM

Rank in Stocks #25809
CEL-SCI Corporation (CVM) focuses on the research and development of... CEL-SCI Corporation (CVM) focuses on the research and development of immune-based therapies to combat cancer and various infectious diseases. Its flagship immunotherapy candidate, Multikine, is currently undergoing Phase III clinical trials for the treatment of head and neck cancer. The company also develops and holds the patent for its preclinical Ligand Epitope Antigen Presentation System (LEAPS), an innovative T-cell modulation technology. This system is designed to stimulate the human immune system to fight a broad range of conditions, including bacterial, viral, and parasitic infections, as well as autoimmune diseases, allergies, transplantation rejections, and various cancers. CEL-SCI's pipeline further includes LEAPS-H1N1-DC, along with LEAPS COV-19, an experimental therapy targeting the COVID-19 coronavirus. Additionally, the company is advancing CEL-2000 and CEL-4000 as potential treatments for rheumatoid arthritis. In a collaborative effort, CEL-SCI has partnered with the University of Georgia's Center for Vaccines and Immunology to progress the LEAPS COVID-19 immunotherapy. Established in 1983, the company's headquarters are located in Vienna, Virginia.
Share Price
$1.35
Last synced: 2026-11-09
Market Cap
$23.75M
Change (1 day)
-6.90%
Change (1 year)
-80.93%
Country

Stock data: Financial Modeling Prep·Updated ·Not investment advice·How we calculate this

Category

Healthcare
Dividend history for CEL-SCI Corporation (CVM)
CEL-SCI Corporation (stock symbol: CVM) made a total of 1 dividend payments.
The sum of all dividends (adjusted for stock splits) is : $62.50
Dividend yield (TTM) : 0.00%
Dividend payments for CEL-SCI Corporation (CVM) from 1996 to 2026
Annual dividend payments
Year Dividend (stock split adjusted) Change
2026 (TTM) $62.50 0.00%
1996 $62.50 0.00%
List of all dividend payments
Year Dividend Change
2026 (TTM) $0.0083 0.00%
1996 $0.0083 0.00%
Dividend payments for similar companies or competitors
Company Number of dividend payments Country
0.00%
US
0.00%
US
67.00%
AU
30.00%
BE
0.00%
NL